These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22769734)

  • 1. Can in vitro fertilization cycles be salvaged by repeat administration of intramuscular human chorionic gonadotropin the day after failed injection?
    Reichman DE; Greenwood E; Meyer L; Kligman I; Rosenwaks Z
    Fertil Steril; 2012 Sep; 98(3):671-4. PubMed ID: 22769734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?
    Reichman DE; Chung P; Meyer L; Greenwood E; Davis O; Rosenwaks Z
    Fertil Steril; 2013 Apr; 99(5):1277-82. PubMed ID: 23290740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro fertilization for Orthodox Jewish couples: antagonist cycle modifications allowing for mikveh attendance before oocyte retrieval.
    Reichman DE; Brauer AA; Goldschlag D; Schattman G; Rosenwaks Z
    Fertil Steril; 2013 Apr; 99(5):1408-12. PubMed ID: 23312229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study.
    Mansour R; Tawab N; Kamal O; El-Faissal Y; Serour A; Aboulghar M; Serour G
    Fertil Steril; 2011 Dec; 96(6):1370-1374.e1. PubMed ID: 22047664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.
    Xu B; Li Z; Zhang H; Jin L; Li Y; Ai J; Zhu G
    Fertil Steril; 2012 Jun; 97(6):1321-7.e1-4. PubMed ID: 22494924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
    Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo maturation of oocytes by extending the interval between human chorionic gonadotropin administration and oocyte retrieval.
    Raziel A; Schachter M; Strassburger D; Kasterstein E; Ron-El R; Friedler S
    Fertil Steril; 2006 Sep; 86(3):583-7. PubMed ID: 16828475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
    Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
    Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falling estradiol levels on day after human chorionic gonadotropin administration in assisted reproductive technology cycles are not predictive of decreasing oocyte maturity or pregnancy rates.
    Levy G; Hill M; Beall S; Pilgrim JD; Payson M; Propst A
    J Reprod Med; 2014; 59(5-6):255-9. PubMed ID: 24937966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles.
    Gremeau AS; Andreadis N; Fatum M; Craig J; Turner K; McVeigh E; Child T
    Fertil Steril; 2012 Aug; 98(2):355-60. PubMed ID: 22658347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early serum beta-human chorionic gonadotropin in pregnancies after in vitro fertilization: contribution of treatment variables and prediction of long-term pregnancy outcome.
    Porat S; Savchev S; Bdolah Y; Hurwitz A; Haimov-Kochman R
    Fertil Steril; 2007 Jul; 88(1):82-9. PubMed ID: 17307176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Logarithmic curves depicting initial level and rise of serum beta human chorionic gonadotropin and live delivery outcomes with in vitro fertilization: an analysis of 6021 pregnancies.
    Shamonki MI; Frattarelli JL; Bergh PA; Scott RT
    Fertil Steril; 2009 May; 91(5):1760-4. PubMed ID: 18455162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower live birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers.
    Ochsenkühn R; Arzberger A; von Schönfeldt V; Gallwas J; Rogenhofer N; Crispin A; Thaler CJ; Noss U
    Fertil Steril; 2012 Aug; 98(2):347-54. PubMed ID: 22633265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders.
    Griffin D; Benadiva C; Kummer N; Budinetz T; Nulsen J; Engmann L
    Fertil Steril; 2012 Jun; 97(6):1316-20. PubMed ID: 22480822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
    Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
    Fertil Steril; 2004 Oct; 82(4):841-6. PubMed ID: 15482757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of human chorionic gonadotrophin (hCG) hormone administration in IVF protocols using GnRH antagonists: a randomized controlled trial.
    Morley L; Tang T; Yasmin E; Hamzeh R; Rutherford AJ; Balen AH
    Hum Fertil (Camb); 2012 Sep; 15(3):134-9. PubMed ID: 22812907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
    Schachter M; Friedler S; Ron-El R; Zimmerman AL; Strassburger D; Bern O; Raziel A
    Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of beta-human chorionic gonadotropin is dependent on day of embryo transfer during in vitro fertilization.
    Kathiresan AS; Cruz-Almeida Y; Barrionuevo MJ; Maxson WS; Hoffman DI; Weitzman VN; Christie DR; Manko GF; Ory SJ
    Fertil Steril; 2011 Dec; 96(6):1362-6. PubMed ID: 22047663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.